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ABSTRACT
Novel strategies of antiinflammatory therapy are based upon pharmacological agents capable to enhance the resolution – i.e. the 
termination of the beneficial inflammation before it may turn into an adverse chronic stage. In contrast to the current therapy, which 
antagonises the formation of proinflammatory mediators, the "proresolving" therapy promotes natural antiinflammatory processes. 
It is likely that several drugs and phytochemicals would act in this way, but this point has not been investigated and thus might 
be totally overlooked. In this paper, effects of curcumin (diferuloylmethane) were analysed, considering the ability of this natural 
compound to affect resolution of inflammation through modulation of its important inputs – activity and apoptosis of neutrophils. 
The presented data indicate that, besides its well-known ability to suppress mechanisms engaged at the onset and progression of 
inflammation, curcumin could support resolution of inflammation through decreased activity and enhanced apoptosis of neutrophils. 
This substance decreased the formation of oxidants in neutrophils, both under in vitro conditions and after oral administration to 
arthritic rats. Moreover, curcumin accelerated spontaneous apoptosis of neutrophils, as indicated by increased externalisation of 
phosphatidylserine, by intercalation of propidium iodide and by enhanced activity of the executioner caspase-3. 
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lipoxins, resolvins, protectins) and programmed death 
of these cells (apoptosis) is initiated. These processes are 
essential for the termination (resolution) of the beneficial 
inflammation (Kohli & Levy, 2009; Serhan et al., 2007). 
An abnormal, ineffective or absent resolution contrib-
utes to tissue damage and to persisting inflammation. 
Moreover, it is thought to participate in the pathogenesis 
of chronic inflammatory disorders, such as asthma, rheu-
matoid arthritis or chronic obstructive pulmonary dis-
ease. Therefore novel strategies of the antiinflammatory 
therapy are based upon pharmacological agents capable 
to enhance the resolution of inflammation. In contrast to 
the current therapy, which antagonises the formation of 
proinflammatory mediators, the “proresolving” therapy 
promotes natural antiinflammatory processes (Filep & 
El Kebir, 2009; Hallett et al., 2008; Rossi et al., 2007). It 
is likely that several drugs and phytochemicals would act 
in this way, but this point has not been investigated and 
thus might be totally overlooked. In this paper effects of 
curcumin (diferuloylmethane) were analysed, considering 
the ability of this natural compound to affect resolution 
of inflammation through modulation of its important 
inputs – activity and apoptosis of neutrophils.
Introduction
Inflammation is a  universal defense response of the 
organism to infection or to tissue injury. During the 
inflammatory process, different cytokines, growth, 
transforming and chemotactic factors are synthesised 
and several types of cells become activated. Neutrophils 
(polymorphonuclear leukocytes) are considered to be 
central cells of acute inflammation. These cells most 
rapidly reach the site of injury or infection and liberate 
antimicrobial proteins, proteases and produce reactive 
oxygen species. Prolonged or excessive liberation of 
these very effective and toxic substances could intensify 
the inflammatory process and enhance tissue damage. 
Therefore activity of neutrophils declines consecutively 
by the effect of antiinflammatory mediators (IL-10, 
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Materials and methods
Chemicals
The highly purified curcumin (diferuloylmethane), lumi-
nol, isoluminol and PMA (phorbol-myristate-acetate) were 
obtained from Sigma (Steinheim, Germany) and metho-
trexate was from Pliva-Lachema (Brno, Czech Republic). 
Human Annexin V/FITC Kit was purchased from Bender 
MedSystems (Vienna, Austria), Caspase-Glo 3/7 Assay from 
Promega (Madison, Wis, USA) and human purified cas-
pase-3 was from Enzo Life Sciences (Lausen, Switzerland).
Neutrophil activity
Activity of neutrophils was evaluated on the basis of 
oxidant formation measured by the chemiluminescence 
method. Under in vitro conditions, isolated human neu-
trophils were stimulated with 0.05 μM PMA and chemilu-
minescence was enhanced either with isoluminol (extra-
cellular) or with luminol in the presence of extracellular 
scavengers – superoxide dismutase and catalase (Nosáľ 
et al., 2009). The effect of orally administered curcumin 
on neutrophil activity was assessed in arthritic rats, in 
compliance with Principles of Laboratory Animal Care 
(Bauerová et al., 2009). The study was approved by the 
State Veterinary and Food Administration of the Slovak 
Republic and by the Ethical Committee at the Institute of 
Experimental Pharmacology and Toxicology. Curcumin 
( 50  mg/kg, daily ) o r meth o tr exa te ( 0.5  mg/kg, twi ce a  
week) was administered orally over a period of 28 days 
after arthritis induction. Then the number of neutrophils 
and the luminol enhanced whole blood chemilumines-
cence (spontaneous or stimulated with 0.01  μM PMA) 
were assessed (Drábiková et al., 2009). The presented 
data, expressed in RLU (relative light units), are based 
on integral values of chemiluminescence over 1  800  s 
(isolated neutrophils) or 3 600 s (whole blood).
Neutrophil apoptosis
Viability of human neutrophils was recorded by flow 
cytometry after double staining with Annexin-V conju-
gated with FITC (fluorescein isothiocyanate) and prop-
idium iodide. Only Annexin positive cells were considered 
pre-apoptotic cells and double positive cells (Annexin+/
propidium+) were considered late-apoptotic or dead cells. 
Caspase-3 activity
Effect of curcumin on caspase-3 activity was evaluated 
in cell-free system by the luminescence method, using 
Caspase-Glo 3/7 Assay kit and human purified caspase-3 
(Perečko et al., 2010). The method is based on caspase 
cleavage of Z-DEVD-amino-luciferin substrate and on 
the light production resulting from the reaction of amino-
luciferin with luciferase. 
Statistical analysis
All values are given as means ± SEM. The statistical sig-
nificance of differences between means was established by 
Student’s t-test and p-values below 0.05 were considered 
statistically significant.
Results
Under  in vitro conditions, curcumin decreased the 
concentration of oxidants, produced by activated neu-
trophils both intra- and extracellularly. However its 
concentration needed for a significant modulation of the 
radicals formed inside neutrophils was 100-times higher 
than that effective extracellularly (Table 1). The effect of 
curcumin on neutrophil activity was further tested under 
in vivo conditions – in arthritic rats. Adjuvant arthritis 
was accompanied by an increased number of neutrophils 
in blood and by a more pronounced spontaneous and 
stimulated chemiluminescence (Table 2). Whereas the 
arthritis related alteration in neutrophil count and in 
spontaneous chemiluminescence were not modified by 
curcumin, the increased reactivity of neutrophils to PMA 
was less evident in curcumin treated animals. The effects 
of curcumin were similar to those of methotrexate – a 
drug widely used in the therapy of arthritic patients.
Curcumin (10 and 100 μM) elevated the percentage of 
preapoptotic and apoptotic neutrophils (Figure 1A) and 
increased the activity of human     recombinant caspase-3 
(Figure 1B). 
Discussion 
Curcumin is a natural antioxidant, displaying remark-
able antiinflammatory and antiarthritic activities (Funk 
et al., 2006; Jagetia & Aggarwal, 2007). These beneficial 
effects have been attributed to the capacity of curcumin 
to prevent activation of nuclear factor-kappa B and the 
subsequent overexpression of proinflammatory media-
tors – cytokines, adhesion molecules, cyclooxygenase-2, 
phospholipase A2, myeloperoxidase, collagenase, as well 
as to its ability to modulate activities of T lymphocytes 
and macrophages (Huang et al., 2004; Sharma et al., 
2005). The presented results indicate that, besides sup-
pression of proinflammatory processes, curcumin could 
promote resolution of inflammation owing to its capacity 
Table 1. Effect of curcumin on neutrophil activity in vitro. 
Curcumin 
(μM)
Percentage of inhibition
Intracellular
chemiluminescence
Extracellular
chemiluminescence
0.01 8.18 ± 4.56 9.92 ± 3.82
0.1 6.93 ± 5.51 15.66 ± 3.84**
1 8.09 ± 6.07 31.03 ± 1.85**
10 81.40 ± 2.43** 86.09 ± 2.30**
100 93.88 ± 1.38** 99.70 ± 0.04**
Formation of reactive oxygen species was measured on the basis of lumi-
nol/isoluminol enhanced chemiluminescence in human neutrophils treated 
with curcumin and stimulated with PMA. Absolute control values of chemi-
luminescence, expressed in relative light units, were 465  200 ± 75  789 RLU 
(intracellular) and 9  487  833 ± 1  125 207 RLU (extracellular). Mean ± SEM, 
n = 6, ** p<0.0113
Also available online on PubMed Central
Interdisciplinary Toxicology. 2011; Vol. 4(1): 11–14
Copyright © 2011 Slovak Toxicology Society SETOX
to accelerate apoptosis of neutrophils and to inhibit oxi-
dative burst of these cells. 
As shown by flow cytometric analysis, curcumin 
enhanced spontaneous apoptosis of neutrophils. This 
was indicated by an increased number of Annexin 
positive cells – i.e. cells displaying a more pronounced 
externalisation of phosphatidylserine. The expression of 
phosphatidylserine on the external side of plasma mem-
brane facilitates the recognition of apoptotic neutrophils 
by macrophages and their safe removal from the site of 
inflammation (Luo & Loison, 2007). At high concentra-
tion (100  μM), curcumin increased the number of late 
apoptotic or dead neutrophils, disclosed on the basis of 
nucleus staining by propidium iodide. Integrity of these 
cells was not destroyed by curcumin treatment and thus 
the discharge of toxic neutrophil contents into the extra-
cellular space was prevented.
The proapoptotic effect was not confirmed under in 
vivo conditions – by a decreased number of neutrophils in 
rats treated with curcumin. This might be due to the lower 
oral bioavailability of curcumin (Aggarwal & Sung, 2008) 
and to the dosage/period of administration – not suf-
ficient to achieve effective concentration in neutrophils.
The ability of curcumin to increase apoptosis has been 
extensively studied in cancer cells (Nair et al., 2010). In 
neutrophils, it was deduced from the altered morphology 
and from the activation of the executioner caspase-3 in 
these cells, resulting from the activation of p38 mitogen-
activated protein kinase (Hu et al., 2005). Our experi-
ments, performed in cell-free system, indicated that direct 
interaction with caspase-3, resulting in increased activity 
of this enzyme, could not be excluded.
Reduced formation of reactive oxygen species in neu-
trophils may represent another mechanism involved in 
0
20
40
60
80
100
120
0 1 10 100
Curcumin (μM)
P
e
r
c
e
n
t
a
g
e
 
o
f
 
c
e
l
l
 
p
o
p
u
l
a
t
i
o
n
live (pre)apoptotic apoptotic/dead
87.5 89.7 72.7 63.7
12.3 10.0
26.5 24.4
11.8
0
25
50
75
100
125
150
1 3 10 30 100
Curcumin (μM)
P
e
r
c
e
n
t
a
g
e
 
o
f
 
c
o
n
t
r
o
l
A B
Figure 1. Neutrophil apoptosis (A) and caspase-3 activity (B) in the presence of curcumin. The life-span of human neutrophils was recorded 
by fl  ow cytometry, using double staining with Annexin-V (AN) and propidium iodide (PI). Of the population of 5 000 granulocytes, the per-
centage of live (AN-/PI-), preapoptotic (AN+/PI-) and apoptotic (AN+/PI+) cells was calculated. The activity of human recombinant caspase-3 
was measured luminometrically, by assessing cleavage of a tagged peptide substrate. Mean ± SEM, n = 5–6.
Table 2. Effect of curcumin on neutrophil activity in arthritis.
Chemiluminescence (RLU)
Number of neutrophils in 
 1 μl of blood Spontaneous PMA stimulated
Control 54 777 ± 3 170 60 412 ± 2 557 8 583 ± 802
Arthritis 84 008 ± 7 841++ 543 700 ± 61 389++ 22 883 ± 1 240++
Arthritis + curcumin 107 898 ± 17 992 187 867 ± 26 611** 28 883 ± 5 865
Arthritis + methotrexate 89 854 ± 15 661 128 200 ± 18 435** 19 540 ± 3 326
Spontaneous and PMA stimulated whole blood chemiluminescence and neutrophil count measured in healthy (control) and not medicated arthritic rats as well 
as in arthritic animals treated with curcumin (50 mg/kg, daily) or with methotrexate (0.5 mg/kg, twice a week). Mean ± SEM, n = 6, ++p<0.01 (vs Control), **p<0.01 
(vs Arthritis), RLU – relative light units.14
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the proresolving activity of curcumin. Oxidants released 
outside neutrophils (potentially dangerous for host tissues) 
were reduced more effectively than oxidants formed within 
neutrophils (involved in elimination of phagocytosed 
pathogens and fulfilling a regulatory role). Compared to 
previous studies (Limasset et al., 1993; Jackson et al., 2006), 
the inhibition was observed at a lower concentration of 
curcumin. Reduced chemiluminescence could result from 
the well-known scavenging activity of curcumin, which 
o r i g i n a t e s  f r o m  t h e  p r e s e n c e  o f  p h e n o l i c  a n d  c e n t r a l  
methylene hydrogens in its molecule (Weber et al., 2005; 
Pari & Murugan, 2006). Moreover, curcumin was found to 
decrease phosphorylation of the signalling enzyme protein 
kinase C (PKC), namely of its two isoforms PKCα and 
PKCβII (Jančinová et al., 2009). Since these isoforms directly 
participate in the activation of the neutrophil NADPH oxi-
dase (Fontayne et al., 2002), their inhibition could result in 
reduced oxidant formation and may explain the decreased 
chemiluminescence observed in the presence of curcumin.
The decreasing effect of curcumin on neutrophil activ-
ity was further observed under in vivo conditions – in 
arthritic rats. Neutrophils modified by inflammation 
produced several times more oxidants than did healthy 
controls and this hyperreactivity was suppressed by 
orally administered curcumin. Since the excessive forma-
tion of radicals was ascribed to the enhanced activity of 
NADPH oxidase in the presence of cytokines (Fairhurst 
et al., 2007; Miesel et al., 1996), the capacity of curcumin 
to prevent activation of nuclear factor-kappa B and the 
subsequent expression of proinflammatory mediators 
(Funk et al., 2006; Huang et al., 2004; Jagetia & Aggarwal, 
2007; Sharma et al., 2005) could be involved in this effect. 
Curcumin-related inhibition of neutrophil oxidative 
burst was comparable with the activity of methotrexate – a 
drug widely used in the therapy of arthritic patients, which 
triggers synthesis of the endogenous anti-inflammatory 
mediator adenosine (Cronstein, 2005) and is thus con-
sidered a “resolution friendly” drug (Serhan et al., 2007).
The presented data indicate that, besides its ability to 
suppress mechanisms engaged at the onset and progres-
sion of inflammation, curcumin could support resolution 
of inflammation through decreased activity and enhanced 
apoptosis of neutrophils.
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